10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.58%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
53.99%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2.39%
Net income growth under 50% of OR's 26.20%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-244.02%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-218.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.18%
Negative 10Y OCF/share CAGR while OR stands at 273.05%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-78.18%
Negative 5Y OCF/share CAGR while OR is at 192.29%. Joel Greenblatt would question the firm’s operational model or cost structure.
-78.18%
Negative 3Y OCF/share CAGR while OR stands at 22738.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
78.75%
Below 50% of OR's 301.80%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
78.75%
5Y net income/share CAGR at 50-75% of OR's 117.59%. Martin Whitman might see a shortfall in operational efficiency or brand power.
78.75%
3Y net income/share CAGR similar to OR's 86.14%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-26.29%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-26.29%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-26.29%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.10%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-6.75%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.16%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.99%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.